Antithrombotic agent usage before ictus in aneurysmal subarachnoid hemorrhage: relation to hemorrhage severity, clinical course, and outcome

BACKGROUND: The number of patients with aneurysmal subarachnoid hemorrhage (aSAH) who are on antithrombotic agents before ictus is rising. However, their effect on early brain injury and disease development remains unclear. The primary aim of this study was to determine if antithrombotic agents (ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kultanen, Hanna, Lewén, Anders, Ronne-Engström, Elisabeth, Enblad, Per, Svedung Wettervik, Teodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140004/
https://www.ncbi.nlm.nih.gov/pubmed/36917361
http://dx.doi.org/10.1007/s00701-023-05556-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140004/
https://www.ncbi.nlm.nih.gov/pubmed/36917361
http://dx.doi.org/10.1007/s00701-023-05556-z

Ejemplares similares